author-photo

Sang Cheul Oh

Korea University

237

Papers

6231

Citations

Citation Trend

Filter By

Papers (170) Sort By

Journal Conference Others

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.

2021 Gastric Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Open-label, phase II study of ladiratuzumab vedotin (LV) for castration-resistant prostate cancer (SGNLVA-005, trial-in-progress).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
FIGHT: A randomized, double-blind, placebo-controlled, phase II study of bemarituzumab (bema) combined with modified FOLFOX6 in 1L FGFR2b+ advanced gastric/gastroesophageal junction adenocarcinoma (GC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
409 Trial in progress: a phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancer

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Prognostic implication of systemic inflammatory markers in young patients with resectable colorectal cancer

2021 Journal of The Korean Surgical Society
Show All
- Source
- Cite
- Save
Citations (0)
643TiP Open-label, phase II study of ladiratuzumab vedotin (LV) for unresectable locally advanced or metastatic solid tumors

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Diagnostic accuracy of CT-staging of advanced gastric cancer following neoadjuvant chemotherapy.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)